Trial Profile
A trial evaluating the effect of dual anti-platelet therapy on major adverse cardiac and cerebral events
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Feb 2016
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Coronary artery disease
- Focus Therapeutic Use
- 27 Feb 2016 New trial record